Latest Breaking News On - Deciphera pharmaceuticals - Page 1 : comparemela.com

Deciphera Pharmaceuticals (NASDAQ:DCPH) Sets New 12-Month High at $25 59

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Free Report)’s stock price hit a new 52-week high during trading on Monday . The company traded as high as $25.59 and last traded at $25.58, with a volume of 366347 shares changing hands. The stock had previously closed at $25.57. Analysts Set New Price Targets A number of […]

United statesCharles schwab investment management incDeciphera pharmaceuticals price performanceInstitutional trading of deciphera pharmaceuticalsDeciphera pharmaceuticalsDeciphera pharmaceuticals incPrincipal financial group incJefferies financial groupDeciphera pharmaceuticals company profileDeutsche bankJpmorgan chase coNews ratings for deciphera pharmaceuticals dailyGet free reportFinancial groupSchwab investment managementInvestment management

Deciphera Pharmaceuticals, Inc (NASDAQ:DCPH) Receives $24 17 Average Price Target from Brokerages

Shares of Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Free Report) have been assigned a consensus recommendation of “Hold” from the ten brokerages that are currently covering the firm, Marketbeat.com reports. Seven equities research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average twelve-month […]

United statesDeciphera pharmaceuticals incDeciphera pharmaceuticals stock performanceDeciphera pharmaceuticalsInstitutional trading of deciphera pharmaceuticalsNews ratings for deciphera pharmaceuticals dailyDeutsche bankDeciphera pharmaceuticals company profileAnalyst recommendations for deciphera pharmaceuticalsDeerfield management companylp seriesJpmorgan chase coFisher asset managementGet free reportAsset managementForest capital managementTrexquant investment

Lycia Therapeutics Lands $106M for Protein Degraders That Treat Autoimmune & Inflammatory Diseases

Lycia Therapeutics Lands $106M for Protein Degraders That Treat Autoimmune & Inflammatory Diseases
medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomLa jollaAl iskandariyahMarshall waceDavid bakerZenas biopharmaEli lillyAsher biotherapeuticsBridgebio pharmaVersant inception sciences discovery engineFranklin templetonDeciphera pharmaceuticalsUniversity of dundeeFrazier life sciencesBristol myers squibb

DCPH Stock Earnings: Deciphera Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024

DCPH Stock Earnings: Deciphera Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Deciphera pharmaceuticals beatsDeciphera pharmaceuticalsMarket newsStock adviceMisses revenue

Zacks Research Weighs in on Deciphera Pharmaceuticals, Inc s Q1 2025 Earnings (NASDAQ:DCPH)

Zacks Research Weighs in on Deciphera Pharmaceuticals, Inc s Q1 2025 Earnings (NASDAQ:DCPH)
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United statesZacks researchHedge funds weigh in on deciphera pharmaceuticalsNews ratings for deciphera pharmaceuticals dailyPrincipal financial group incJpmorgan chase coDeciphera pharmaceuticals incChina universal asset management coJefferies financial groupPanagora asset management incDeciphera pharmaceuticalsDeciphera pharmaceuticals stockFree reportDeciphera pharmaceuticalFinancial groupGet free report